Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Osheiza Abdulmalik, PhD
Researcher Research Associate II
Perelman School of Medicine
University of Pennsylvania
Rivella Lab
3615 Civic Center Blvd
Room 316B
Abramson Research Center
Philadelphia, Pennsylvania, United States
Dr. Abdulmalik’s research interests broadly encompass the hemoglobinopathies and red blood cell disorders, with particular focus on sickle cell disease and beta-thalassemia. Though both disorders are consequences of simple genetic mutations, the implications of these mutations are inherently complex, and include significant morbidities, lifelong challenges, reduced quality of life, and early mortality in patients; as well as substantial healthcare burden on families, caregivers, and society in general.
Dr. Abdulmalik’s current research focuses on three modalities of countering disease pathophysiology. The first approach, in tandem with a multidisciplinary team of collaborators, utilizes medicinal chemistry and structural biology to design novel drugs that block the primary pathophysiology of sickle cell disease, i.e., the polymerization of sickle hemoglobin.
Representative Publications:
Crystal structure of carbonmonoxy sickle hemoglobin in R-state conformation
+myBinderRelated Content
-
Martin H. Steinberg, MDDr. Steinberg is currently working as pr...
-
Carlton Haywood, Jr., PhD, MABorn January 26, 1976, in Atlanta, Georg...
-
The 2020 ASPHO Conference – CANCELEDMore than 1,200 pediatric hematology/onc...
-
Today’s Faces of Sickle Cell Disease: Wanda Whitten-Shurney, MDWanda Whitten-Shurney is a pediatrician,...
-
Integration of neuropsychology services in a sickle cell clinic and subsequent healthcare use for pain crisesObjective: Growing literature has docum...
-
Annual Sickle Cell Disease and Thalassaemia Conference (ASCAT) 2022The Annual Scientific Conference on Sick...
-
Howard University Hospital Center for Sickle Cell DiseaseTransitioning from pediatric to adult pr...
